Identification of Biomarkers in Spinocerebellar Ataxia 3
Status: Completed
Location: See location...
Intervention Type: Other
Study Type: Observational
SUMMARY
The purpose of this study is to examine the differences in cerebral spinal fluid (CSF) and blood of patients with spinocerebellar ataxias and healthy volunteers. The goal of this project is to identify new biomarkers that are useful for characterizing spinocerebellar ataxias and identify targets for treatment or prevention of this condition.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: t
View:
• •Confirmed Genetic Testing of SCA3 or Healthy Volunteers
Locations
United States
Michigan
University of Michigan
Ann Arbor
Time Frame
Start Date: 2019-02-21
Completion Date: 2023-01-04
Participants
Target number of participants: 22
Treatments
Affected Individuals with Known SCA3
In order to be eligible for this cohort, participants must have confirmed genetic testing results for Spinocerebellar Ataxia Type 3.
Healthy Individual Control Subjects
In order to be eligible for this cohort, subjects must not have a diagnosis of Spinocerebellar Ataxia Type 3 and no major medical issues including but not limited to conditions that would cause an unsafe specimen collection.
Authors
Related Therapeutic Areas
Sponsors
Leads: University of Michigan
Collaborators: National Institutes of Health (NIH), National Institute of Neurological Disorders and Stroke (NINDS)